| Literature DB >> 31704710 |
Vishnu Janardan1, Sanjeev Sharma1, Urbashi Basu1, Padinjat Raghu2.
Abstract
Phosphoinositides are lipid signaling molecules that regulate several conserved sub-cellular processes in eukaryotes, including cell growth. Phosphoinositides are generated by the enzymatic activity of highly specific lipid kinases and phosphatases. For example, the lipid PIP3, the Class I PI3 kinase that generates it and the phosphatase PTEN that metabolizes it are all established regulators of growth control in metazoans. To identify additional functions for phosphoinositides in growth control, we performed a genetic screen to identify proteins which when depleted result in altered tissue growth. By using RNA-interference mediated depletion coupled with mosaic analysis in developing eyes, we identified and classified additional candidates in the developing Drosophila melanogaster eye that regulate growth either cell autonomously or via cell-cell interactions. We report three genes: Pi3K68D, Vps34 and fwd that are important for growth regulation and suggest that these are likely to act via cell-cell interactions in the developing eye. Our findings define new avenues for the understanding of growth regulation in metazoan tissue development by phosphoinositide metabolizing proteins.Entities:
Keywords: Drosophila melanogaster; Phosphoinositides; cell growth; metazoan
Mesh:
Substances:
Year: 2020 PMID: 31704710 PMCID: PMC6945015 DOI: 10.1534/g3.119.400851
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Phosphoinositide metabolism in eukaryotic cells. Phosphatidylinositol (PI) is synthesized from phosphatidic acid (PA) via cytidine diphosphate diacylglycerol (CDP-DAG). This involves the action of CDP-DAG synthase (CDS) and PI synthase (PIS) enzymes. Phosphatidylinositol thus formed can be phosphorylated to form phosphoinositides which are interconverted by various kinase and phosphatase reactions (green and black arrows respectively). Kinase reactions that are not well established are indicated by green dotted arrows. The phosphoinositide PI(4,5)P2 is converted to diacylglycerol (DAG) by the action of phospholipase C (). DAG is then converted to PA and recycled back to form PI (blue arrows). The inset represents PI-transfer proteins (PITPs) that function to transfer PI (and PA) between membranes. All the genes identified to modulate growth in our screen are marked in red.
List of Drosophila phosphoinositide signaling genes used for the screen and a summary of the results. Gene names along with their FBgn numbers, CG numbers and closest human orthologs are listed. For each of these genes, the various VDRC and TRiP RNAi lines used and the phenotypes observed with each are reported. In the CoinFLP mosaic analysis, the severity of the phenotype is represented by ‘+’, with ‘+++’ being the most severe (wherein the knockdown clones are completely absent) and ‘+’ being the mildest. The positive hits are represented by bold text
| CoinFLP RNAi screen | Act > y+>Gal4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| FBgn | CG # | VDRC # | BL # | Wild-type | Cell elimination | Overgrowth | Others | |||
| FBgn0037339 | CG2929 | Pi4KIIα | PI4K2A | v25458 | + | |||||
| v25459 | ++ | |||||||||
| v40995 | + | |||||||||
| v110687 | + | |||||||||
| PI4KA | v105614 | +++ | ||||||||
| v15993 | +++ | Lethal | ||||||||
| BL35643 | + | |||||||||
| BL35256 | + | |||||||||
| PI4KB | v110159 | ++ | ||||||||
| v27786 | +++ | Smaller eyes. May affect patterning | Normal eyes | |||||||
| v27785 | + | |||||||||
| BL29396 | ++ | |||||||||
| BL31187 | + | |||||||||
| BL35257 | + | |||||||||
| v6231 | +++ | Smaller eyes. May affect patterning | Smaller eyes | |||||||
| v6229 | +++ | |||||||||
| BL35198 | + | |||||||||
| BL27715 | +++ | Crunched eyes. May affect patterning | ||||||||
| FBgn0034789 | CG3682 | PIP5K59B | PIP5K1A | v108104 | + | |||||
| v47027 | + | |||||||||
| v47029 | + | |||||||||
| FBgn0039924 | CG17471 | PIP4K | PIP4K2B | BL35338 | + | |||||
| BL35660 | + | |||||||||
| BL65891 | + | |||||||||
| FBgn0028741 | CG6355 | fab1 | PIKFYVE | v27591 | + | |||||
| v27592 | + | |||||||||
| BL35793 | + | |||||||||
| PIK3CD | v107390 | + | ||||||||
| v38986 | + | |||||||||
| v38985 | +++ | Smaller eyes | Smaller eyes | |||||||
| BL35798 | + | |||||||||
| BL27690 | +++ | Smaller eyes | ||||||||
| BL61182 | ++ | |||||||||
| PIK3C2A | v109582 | ++ | Crunched eyes | |||||||
| v16240 | + | |||||||||
| v16239 | + | |||||||||
| BL35265 | + | |||||||||
| BL34621 | + | |||||||||
| BL31252 | ++ | Normal eyes | ||||||||
| PIK3C3 | v100296 | +++ | Crunched eyes and antennae | Normal eyes | ||||||
| BL36056 | + | |||||||||
| BL33384 | + | |||||||||
| BL64011 | ++ | Rough/ glossy clones | ||||||||
| PIK3R3 | v104179 | +++ | Crunched eyes. May affect patterning | Smaller eyes | ||||||
| v33556 | ++ | |||||||||
| BL36810 | + | |||||||||
| BL38991 | +++ | |||||||||
| FBgn0025742 | CG9115 | myotubularin (mtm) | MTMR2 | v29032 | + | |||||
| BL38339 | + | |||||||||
| BL31552 | + | |||||||||
| BL57298 | + | |||||||||
| FBgn0030735 | CG3632 | MTMR4 | v110167 | + | ||||||
| v26254 | + | |||||||||
| BL38341 | + | |||||||||
| FBgn0028497 | CG3530 | MTMR7/8 | v110786 | + | ||||||
| v26216 | ++ | |||||||||
| v26217 | +++ | |||||||||
| BL38340 | + | |||||||||
| BL25864 | + | |||||||||
| FBgn0035945 | CG5026 | MTMR9 | v105674 | + | ||||||
| v34915 | + | |||||||||
| v34916 | + | |||||||||
| BL42759 | + | |||||||||
| BL38309 | + | |||||||||
| BL57020 | + | |||||||||
| PTEN | v101475 | + | ||||||||
| v35371 | + | |||||||||
| BL25841 | + | |||||||||
| BL25967 | + | |||||||||
| BL33643 | + | Larger eyes | ||||||||
| FBgn0036058 | CG6707 | PIP4P1 | v110291 | +++ | Smaller eyes | |||||
| v44557 | + | |||||||||
| v44556 | + | |||||||||
| BL28316 | + | |||||||||
| FBgn0259166 | CG42271/ CG33248 | INPP4A | v100176 | ++ | ||||||
| v41672 | + | |||||||||
| BL29411 | + | |||||||||
| SACM1L | v44376 | +++ | ||||||||
| v37217 | +++ | |||||||||
| v37216 | + | |||||||||
| BL56013 | +++ | Lethal | ||||||||
| FBgn0031611 | CG17840 | FIG4 | FIG4 | v107084 | + | |||||
| v45037 | +++ | |||||||||
| v45038 | +++ | |||||||||
| BL38291 | + | |||||||||
| BL58063 | + | |||||||||
| FBgn0023508 | CG3573 | Ocrl | INPP5B | v34649 | + | |||||
| v110796 | + | |||||||||
| BL34722 | + | |||||||||
| FBgn0034691 | CG6562 | Synaptojanin (Synj) | SYNJ1 | v46070 | + | |||||
| BL44420 | + | |||||||||
| BL34378 | + | |||||||||
| BL27489 | + | |||||||||
| FBgn0030761 | CG9784 | Phosphoinositide 5-phosphatase | v108075 | + | ||||||
| v30098 | + | |||||||||
| BL34723 | + | |||||||||
| FBgn0036273 | CG10426 | INPP5E | INPP5E | v16048 | + | |||||
| BL41701 | + | |||||||||
| BL34037 | +++ | |||||||||
| FBgn0038890 | CG7956 | INPP5F | v22638 | + | ||||||
| v22637 | Smaller eyes. Rough/ glossy clones | |||||||||
| CDIPT (PIS) | v11852 | +++ | Lethal | |||||||
| v106842 | ++ | |||||||||
| BL29383 | +++ | |||||||||
| BL55602 | + | |||||||||
| FBgn0004611 | CG4574 | Plc21C | PLCB1 | v108395 | Lethal | |||||
| v26558 | + | |||||||||
| v26557 | + | |||||||||
| BL33719 | + | |||||||||
| BL32438 | + | |||||||||
| BL31269 | + | |||||||||
| BL31270 | + | |||||||||
| FBgn0262738 | CG3620 | norpA (PLCβ) | PLCB4 | v21490 | +++ | Smaller eyes | ||||
| v105676 | ++ | May affect patterning | ||||||||
| BL31113 | + | |||||||||
| BL31197 | + | |||||||||
| FBgn0003218 | CG11111 | rdgB | PITPNM2 | v6226 | Rough/ glossy clones | |||||
| BL28796 | + | |||||||||
| FBgn0027872 | CG17818 | rdgBβ | PITPNC1 | v19089 | + | |||||
| v104799 | + | |||||||||
| BL44523 | + | |||||||||
| FBgn0003416 | CG4200 | small wing (PLCγ) | PLCG1 | v7173 | ++ | |||||
| v7174 | ++ | |||||||||
| v108593 | + | |||||||||
| BL32385 | + | |||||||||
| BL32906 | + | |||||||||
| BL35604 | + | |||||||||
| FBgn0010350 | CG7962 | Cds | CDS1/2 | BL28075 | + | |||||
| BL58118 | + | |||||||||
Figure 2Overall strategy of the screen. (A) A list of all the genes screened. (B) A flowchart of the screen indicating number of genes screened and number of RNAi lines selected at each stage. (C) Graphical representation of (i) the CoinFLP system that results in two populations of cells. One population undergoes FLP mediated recombination at the FRT3 sites (cyan triangles), thus retaining the STOP cassette (gray) and not expressing Gal4. Ommatidia formed by these cells appear red in color. In the other population, recombination between FRT sites (yellow triangles) results in removal of the STOP cassette, thus activating Gal4 under the Actin 5c promoter. Ommatidia formed by these cells appear white in color due to expression of white transgene under control of UAS. Various RNAi lines (indicated by UAS-X) can be used to target genes in these cells to generate mosaics (Adapted from Bosch ) and (ii) the possible outcomes and inferences from the generated mosaics. (D) Graphical representation of (i) whole-eye expression of Gal4 under the Actin 5c promoter. In these eye discs, recombination at the FRT sites (yellow triangles) results in activation of Gal4 in all cells expressing FLP under the eyeless promoter and (ii) the possible outcomes and inferences from this.
Figure 3Hits identified from the screen. Representative images of (A) controls and genes that were identified to cell autonomously regulate growth. (B) Genes identified to regulate cell growth via cell-cell interaction. (C) Area of eyes after whole-eye knockdown of genes was determined by drawing an outline as indicated in Figure 3A(i’) and plotted. Dotted line indicates the area of control eyes for comparison with those of tested RNAi lines.